Transforming growth factor (TGF)-b has a dual role in liver, providing cytostatic effects during liver damage and regeneration, as well as carcinogenic functions in malignant transformation and hepatocellular cancer. In cultured hepatocytes, TGF-b can trigger apoptosis and epithelial-mesenchymal transition (EMT). Caveolin-1 is associated with progression of hepatocellular cancer and has been linked to TGF-b signaling. This study aimed at elucidating whether Caveolin-1 regulates TGF-b mediated hepatocyte fate. Knockdown of Caveolin-1 strongly reduced TGF-b mediated AKT phosphorylation, thus sensitized primary murine hepatocytes for proapoptotic TGF-b signaling. Restoration of AKT activity in Caveolin-1 knockdown cells via expression of a constitutive active AKT mutant did not completely blunt the apoptotic response to TGF-b, indicating an additional mechanism how Caveolin-1 primes hepatocytes for resistance to TGF-b triggered apoptosis. On the molecular level, Caveolin-1 interfered with TGF-b initiated expression of the proapoptotic mediator BIM. Additionally, RNAi for Caveolin-1 reduced (and its overexpression increased) expression of antiapoptotic mediators BCL-2 and BCL-xl. Noteworthy, reduced Caveolin-1 protein levels had no effect on collagen 1a1, E-and N-cadherin expression upon TGF-b challenge and thus no effect on hepatocyte EMT. Hence, via affecting TGF-b mediated non-Smad AKT signaling and regulation of pro-and antiapoptotic factors, Caveolin-1 is a crucial hepatocyte fate determinant for TGF-b effects. Transforming growth factor (TGF)-b is a pleiotropic cytokine that regulates many cellular events, such as proliferation, differentiation, migration and death. TGF-b binds to its cognate serine/threonine kinase receptors type I and II (TbRI/ALK5 and TbRII) to initiate signal transduction. Ligand binding leads to transactivation of TbRI/ALK5 by the type II receptor. Consequently, the type I receptor facilitates phosphorylation of R-Smads, namely Smad2 and Smad3. Activated R-Smads then heteromerize with Smad4, thereby increasing their nuclear presence to regulate gene expression. Besides the canonical Smad pathway, TGF-b can initiate the activation of other signaling molecules, among ERK, JNK, p38, PI3K/AKT. However, this non-canonical signaling is cell type dependent.
1
In hepatocytes, TGF-b can exert an epithelial mesenchymal transition (EMT) as well as trigger apoptosis. The EMT process is accompanied by loss of cell polarity and cell-cell contacts (for example, via downregulation of E-cadherin and zonula occludens) and upregulation of mesenchymal markers such as Snai1, vimentin and N-cadherin that has been shown by us and other groups. [2] [3] [4] Although solid evidences exist about hepatocyte EMT in vitro, 5 in vivo transition is still under debate. 6 Simultaneously to EMT, TGF-b induces apoptosis of a fraction of cultured hepatocytes. Moreover, TGF-b was shown to be a potent elicitor of hepatocyte apoptosis in vivo. 7 The mechanisms how apoptosis is triggered by TGF-b are diverse. Amongst are cooperation of TGF-b with FasL or TNF-a and also activation of MAPK pathways like p38 and JNK. 8 Even more, TGF-b can modulate NF-kB and therewith influence cell survival. In hepatocytes, TGF-b mediates its apoptotic function via induction of ROS and also of the proapoptotic protein BIM and thereby inducing the mitochondrial cell death pathway. 9, 10 This then culminates in the activation of effector caspases like caspase 3. To date, it is unclear what factors regulate the decision for the cells' fate. Hints come from studies, which demonstrate that the Smad3/ pAKT ratio might influence whether apoptosis is induced or not. [11] [12] [13] Indeed, in cultured hepatocytes, TGF-b is capable of rapidly activating AKT which thus might direct the cells towards EMT. 14 In this study, we report about Caveolin-1 being essential for TGF-b mediated activation of AKT in hepatocytes. Caveolin-1 is required for the formation of caveolae in lipid rafts on the plasma membrane, and TGF-b receptors were previously shown to internalize via caveolae. 15 This internalization route was linked with receptor downregulation and abrogation of signaling. Caveolin-1 offers a scaffold for diverse signaling proteins and thus influences a variety of cellular events.
Further, we show that EMT markers are not altered by Caveolin-1 knockdown, whereas significant differences were found for apoptosis-related genes. We therefore conclude that, Caveolin-1 primes hepatocytes for apoptotic triggers and offers an environment for non-Smad signaling, which might determine hepatocyte fate upon TGF-b challenge.
Results
TGF-b regulates genes involved in apoptosis and EMT in hepatocytes. Primary murine hepatocytes were stimulated with TGF-b1 for 24 h and a microarray analysis was performed to elucidate expression changes of genes related to apoptosis. Intriguingly, TGF-b is capable of regulating both pro and antiapoptotic genes ( Table 1) . This underlines that TGF-b mediated hepatocyte programmed death is tightly regulated. Therefore, players have to exist which decide about the hepatocyte fate in response to the availability of TGF-b.
Caveolin-1 knockdown increases canonical Smad signaling and abrogates TGF-b mediated AKT activation. Caveolin-1 was shown to be a critical regulator of TGF-b receptor availability, which subsequently affects TGF-b signaling. Knocking down Caveolin-1 in hepatocytes did not change Smad3 activation, but significantly prevented phosphorylation of AKT (densitometry: siCo þ TGF-b versus siCav þ TGF-b: 2.0 ± 0.3 versus 1.2 ± 0.3, P ¼ 0.011, n ¼ 4) within 30 min of TGF-b1 treatment (Figure 1a) and. 18 Total levels of Smad3 and AKT were not altered by the Caveolin-1 knockdown (not shown). However, applying a Smad luciferase reporter assay, TGF-b1 treated Caveolin-1 knockdown hepatocytes culminated in a significant enhancement of luciferase activity, when compared with controls ( Figure 1b , P ¼ 0.0087). In contrast, elevated levels (via adenoviral Caveolin-1 gene transfer) of Caveolin-1 did not result in changes in AKT activation and total expression, although basal AKT activity was slightly enhanced in AdCav transduced hepatocytes. Also expression of Smad3 (not shown) and the Smad reporter assay (Figures 1c and d (Figure 1f ).
In line with the findings on TGF-b1 activated signaling cascades, AdCav-1 transduced cells do not show significant changes in the caspase 3 assay (Figure 1g ; n ¼ 3, P ¼ 0.14). This highlights that physiologic expression of Caveolin-1 is critical for hepatocyte fate determination towards apoptosis or EMT.
Abrogation of AKT activation enhances TGF-b mediated apoptosis. Although absence of Caveolin-1 increased the canonical Smad pathway in hepatocytes upon TGF-b stimulation, we hypothesized that the non-initiation of the AKT branch may be of relevance for the increased caspase 3 activity. This explanation is supported from the results of Caveolin-1 overexpression which did not reduce the CAGALuc reporter assay. To determine the effect of the AKT pathway on TGF-b mediated apoptosis, we used the PI3K/ AKT inhibitor Ly294002 to blunt AKT activity. TGF-b induced apoptosis was strongly elevated in the absence of AKT signaling (Figure 2a ), whereas basal caspase 3 activity was not elevated by Ly294002 and therewith toxicity of the activation.
Noteworthy, although caAKT reduced apoptosis also in siControl cells, its overexpression did not completely blunt TGF-b mediated apoptosis in hepatocytes.
Caveolin-1 knockdown affects BCL2, BCL-xl and BIM expression. A main mechanism how TGF-b1 triggers the apoptotic cascade is the regulation of BCL family members that consist of pro-and antiapoptotic proteins. Hence, we first investigated the expression of the proapoptotic factor BIM, which has been previously linked to TGF-b mediated apoptosis in hepatocytes. [20] [21] [22] Basal BIM expression was not altered in siCaveolin-1 samples compared with siControl (Figure 3a) . Further, mRNA analysis of TGF-b treated siControl and siCaveolin-1 hepatocytes confirmed a significant elevation of BIM expression in the absence of Caveolin-1 (Figure 3b , n ¼ 3, P ¼ 0.043). In this context, the activation of the AKT pathway has been reported to negatively regulate BIM activity and expression. [22] [23] [24] As the balance between pro-and antiapoptotic proteins determines the fate of cells, we addressed whether the antiapoptotic proteins BCL2 and BCL-xl were affected by Caveolin-1 knockdown. Knockdown of Caveolin-1 correlated significantly with a reduction of BCL2 (n ¼ 4, P ¼ 0.011) and BCL-xl mRNA expression (n ¼ 3, P ¼ 0.037) (Figures 3c  and d) . On the contrary, overexpression of Caveolin-1 culminated in elevated basal expression of BCL2 and BCL-xl (BCL2: 1.845±0.26, n ¼ 5, P ¼ 0.013; BCL-xl: 1.81±0.43, n ¼ 5, P ¼ 0.093; Figure 3e ). TGF-b potently downregulated mRNA levels of BCL2 (n ¼ 4, P ¼ 0.010) and BCL-xl (n ¼ 3, P ¼ 0.007) in siControl samples, but likely due to the low basal expression of these targets, no further significant reduction was identified in siCaveolin-1 þ TGF-b samples as compared with siCaveolin-1 untreated. However, BCL2 and BCL-xl levels are also significantly reduced when comparing siCaveolin-1 þ TGF-b1 versus siControl (BCL2: n ¼ 4, P ¼ 0.0092; BCL-xl: n ¼ 3, P ¼ 0.038). Taken together, our data argue for Caveolin-1 possessing priming effects towards an apoptotic response after a TGF-b challenge.
EMT markers are not altered by Caveolin-1 knockdown. A subsequent question to answer was whether the shift towards apoptosis affects the TGF-b mediated EMT process in the surviving hepatocytes. Therefore, Caveolin-1 was knocked down (490% knockdown on mRNA level, not shown) and mRNA levels for Collagen 1a1 and Snai1 in TGF-b1 treated cells were analyzed. TGF-b potently induced expression of the EMT markers. When comparing the fold induction between siControl þ TGF-b1 versus siCaveolin-1 þ TGF-b1, no significant change could be identified. Collagen 1a1 was increased 1.2-fold (±0.24, n ¼ 3, P ¼ 0.25) in siCaveolin-1 þ TGF-b samples and Snai1 expression was elevated 2.76-fold ( ± 2.4, n ¼ 3, P ¼ 0.274), respectively (Figure 4a ). For further validation, downregulation of E-Cadherin, upregulation of N-Cadherin and Pai1 by TGF-b1 in control and Caveolin-1 knockdown hepatocytes were assessed on protein level (Figure 4b) . In both settings, no difference in repression of E-Cadherin and induction of N-Cadherin and Pai1 was found, as determined by densitometric analysis (Figures 4c-e) . To conclude, the surviving 
Discussion
Hepatocytes respond to TGF-b in a bivalent way. One fraction undergoes apoptosis, whereas the surviving cells obtain a mesenchymal phenotype (as they undergo EMT). Here, we define the activation of AKT being relevant for hepatocyte survival upon TGF-b challenge. Absence of Caveolin-1, an essential protein for caveolae formation on the plasma membrane, abrogated TGF-b mediated phosphorylation of AKT, which culminated in increased hepatocyte apoptosis. A recent study proposed that, TGF-b mediated activation of AKT is facilitated via EGFR (epidermal growth factor receptor) ligand secretion, EGFR activation and subsequent c-Src phosphorylation. 25 However, Caveolin-1 was shown to counteract EGFR signaling. 26, 27 Instead, EGFR propagate downstream signaling via clathrin-coated pit internalization and thus, the lack of Caveolin-1 should not affect TGF-b mediated activation of AKT. The general role of Caveolin-1 in regulating AKT activation is evident. PI3K/AKT signaling has recently been shown to require lipid raft compartments (where Caveolin-1 is usually located) to enable activation. [28] [29] [30] [31] Further, a Caveolin-1 dependent signaling cascade involving RhoA/ROCK/PI3K/AKT has been described. 32 Further research activities will shed light on how TGF-b induces AKT in a Caveolin-1 dependent manner.
Noteworthy, this study points out that endocytosis acts as a regulator of TGF-b signaling outcome in hepatocytes. Although it was proposed that TGF-b signaling is enhanced via clathrin-coated pit internalization and the caveolae/ Caveolin-1 dependent route would serve for dampening of signaling, 33 the presented work demonstrates that first, Caveolin-1 is required for activation of AKT by TGF-b and subsequently second, that reduced Caveolin-1 levels shift the physiological hepatocyte response towards apoptosis. Thus, Caveolin-1 regulates signaling not only by enhancing or dampening of the signal strength, but enables modulation which cellular program, EMT or apoptosis, is initiated. A further note against the general assumption of Caveolin-1 as a delimiter of TGF-b signaling, our data clearly show that the effects of altered Caveolin-1 expression levels can not be generalized. Knockdown did not result in a general enhancement of repression or elevation of TGF-b1 target genes, as exemplified on Collagen 1a1, E-and N-Cadherin. These observations further argue for Caveolin-1 being a modulator of the TGF-b pathway instead of being only responsible for the downregulation of surface receptors. Next, endogenous expression levels of Caveolin-1 are sufficient to facilitate AKT activation as its overexpression did neither affect the reporter, nor alter the caspase 3 assay significantly. However, AdCav transduction reduced enzyme activities moderately in the caspase 3 assay. This finding might be of relevance in the pathogenesis of hepatocellular carcinomas, as it was reported that Caveolin-1 is frequently overexpressed in tumor tissues. 34, 35 However, the effects on pathogenesis are not fully solved and contradictory correlations between Caveolin-1 expression and disease progression have been discussed. 34, 36 From the presented data, it is likely that the endogenous pool of Caveolin-1 is enough to generate an environment (for example, caveolae), in which activation of AKT by TGF-b can be accomplished. A further increase of caveolae formation thus would not affect physiologic AKT activation. Hence, the observed slight reduction of Smad signaling and caspase 3 activation in Caveolin-1 overexpressing cells might derive from the previously described function of caveolae with respect to TGF-b receptor degradation. 22 Intriguingly, a hyperactivation of the AKT pathway did not further reduce the basal TGF-b mediated apoptotic process. This implies that a basal apoptotic rate is AKT signaling independent, but likely relies on Smad3-mediated signal transduction. Smad3 has previously been shown as essential for TGF-b mediated apoptosis in hepatocytes.
14 Recently, a milestone paper about the metabolic effects of Caveolin-1 deficiency was published. Bosch et al. report that deficiency alters the Caveolin-1 knockdown leads to increased TGF-b1 mediated Smad signaling paralleled by absence of AKT activation. Antiapoptotic BCL2 and BCL-xl expression are affected by knockdown of Caveolin-1. As a consequence, hepatocyte apoptosis is elevated. The EMT branch is unaltered upon Caveolin-1 knockdown as illustrated by N-cadherin, E-cadherin and Collagen 1a1 expression mitochondrial membrane composition and subsequently affects the respiratory chain. 37 Subsequently, more cell stress was measured. These findings offer an additional mechanism on the role of Caveolin-1 affecting the cell response to proapoptotic stimuli. Even more, our findings on basal BCL2 and BCL-xl expression might be explained by the above reported function that Caveolin-1 deficiency induces cell stress and subsequently shifts the balance to enhanced susceptibility for apoptosis. Confirming the influence of Caveolin-1 on basal apoptosis susceptibility, elevated Caveolin-1 expression levels affected expression of BCL2 and BCL-xl in a positive way. To conclude, our study proves that Caveolin-1 is a major modulator of the TGF-b pathway (illustrated in Figure 4f ). Caveolin-1 is priming hepatocytes for proapoptotic stimuli and its expression is a prerequisite for TGF-b triggered AKT activation and hence sets the course for the hepatocyte fate.
Materials and Methods
Cell culture. Wild type primary hepatocytes were isolated from livers of male C57Bl/6 by collagenase perfusion. 38 Hepatocytes then were plated on collagen coated plates and cultured as described 14 in Williams E medium supplemented with l-glutamine, dexamethasone and foetal calf serum. After attachment (4-h), cells were kept in starvation medium without dexamethasone and foetal calf serum.
